ASLS recognized for its industry-leading 3D bioprinting and vascularization solutions for life scientists, drug developers, and tissue engineers.
BOSTON, MA. & LOUISVILLE, KY. – 10 December, 2019 – Based on its recent analysis of global manufacturing for pharmaceuticals, biotechnology, and cell & gene therapies, Frost & Sullivan recognizes Louisville-based Advanced Solutions Life Sciences, LLC (ASLS) with the 2019 Bioprinting Value Leadership Award. ASLS has demonstrated leadership in the category by introducing innovative, best-in-class biofabrication hardware, software, and consulting services. Its flagship product is the BioAssemblyBot®, the world’s only 3D bioprinter that gives users the flexibility, speed, and precision of a six-axis robotic arm to translate regenerative medicine therapies from benchtop-to-bedside.
“ASLS is an organization grounded in customer satisfaction & continuous improvement, delivering true value through their market-leading 3D bioprinters. It has developed an extensive ecosystem comprising of biofabrication, vascularization and machine learning software to support adjacent applications in research laboratories to biopharmaceutical factories,” said Aarti Chitale, Senior Research Analyst, Life Sciences, Frost & Sullivan. “ASLS is drastically simplifying the tissue engineering workflow, while expanding experimental throughput by 20x in most cases”
While 3D bioprinting has become an essential tool for drug developers, procurement of bioprinting systems and hardware requires significant capital expenditures and highly trained resources to operate these instruments, which imposes significant cost challenges tied to training and procurement, especially for small and mid-segment players. Frost & Sullivan has identified Advanced Solutions Life Sciences as a leading developer of unique, easy-to-use, and cost-effective solutions to support advancement of life-saving drugs via 3D bioprinting, especially focused on the tissue engineering segment.
“We’re honored to be recognized by Frost & Sullivan as the industry leader in the 3D bioprinting category,” said Michael Golway, Co-Founder and CEO of ASLS. “We are committed to continually improving BioAssemblyBot® to better serve our customers’ applications and deliver trusted, high-performance biofabrication solutions to leading research labs across the globe.”
ASLS demonstrates an unparalleled focus supporting curative therapy research, with its one-of-a-kind BioAssembly™ and Angiomics™ technology platforms. Its technology stands out from the competition by using biomimetic robotics and natural circulatory pathways to create functional vasculatures for engineered tissues and organs. The company is strongly positioned across the United States, securing research and development grants from NIH and ARMI to create specialized manufacturing workflows for clinical and non-clinical commercial activities. Its cost-effective products ensure its strong market positioning as well as a growing customer base.
Frost & Sullivan strongly believes that ASLS’s products have the potential to encourage cutting-edge scientific discoveries and pave the way towards developing advanced medical technologies for the overall betterment of humanity.
The full report is available at www.lifesciences.solutions/frost
About Advanced Solutions Life Sciences:
Advanced Solutions Life Sciences (ASLS) is dedicated to the discovery, design, and development of integrated software and hardware solutions for the fields of science that involve living organisms, molecular biology, and biotechnology. ASLS offers a full-service business model including its patented, cGMP and UL certified BioAssemblyBot® Technology Platform, BioBot® Basic platform, TSIM® and BioApps® Software, VIPM™, and Professional Services.
Visit www.bioassemblybot.com for more information.
+1 (502) 815-2052
About Frost & Sullivan:
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community.
+1 (210) 477-8457
Company Name: Advanced Solutions Life Sciences
Contact Person: Derek Mathers
Email: Send Email
Address:3513 Brighton Blvd Suite 400
Country: United States